Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-09-12)Premium Content

Alkermes Plc (ALKS)

2014-11-27@08:07:53 ET
Form 4: Update Filing for Alkermes PLC (ALKS) (VKR)

2014-11-26@17:59:06 ET
Uptrend Call Working As Alkermes Stock Rises 26.0% (ALKS) (PSM)

2014-11-26@11:57:25 ET
Alkermes (ALKS) Showing Bullish Technicals With Resistance At $57.48 (FBM)

2014-11-26@08:11:38 ET
Short-term Underperformance Detected in Shares of Incyte in the Biotechnology Industry (INCY, ALKS, SGMO, CLDX, SCLN) (F70)

2014-11-25@18:18:43 ET
Look for Shares of Alkermes to Potentially Rebound after Yesterday's 3.09% Sell Off (PSM)

2014-11-25@16:02:13 ET
Alkermes' Corporate Presentation to be Webcast at The NASDAQ OMX 31st Investor Program (BIZ)

2014-11-25@11:56:21 ET
Shares of Alkermes Under Pressure, Down 1.8% (F77)

2014-11-25@08:11:33 ET
Alkermes has Relatively Underperformed its Peers in the Biotechnology Industry (ALKS, MNKD, OREX, RGEN, PCYC) (F70)

2014-11-24@15:14:04 ET
Alkermes: The Winning Streak Continues (ALKS) (F71)

2014-11-24@11:56:02 ET
Highest Debt to EBITDA Ratio in the Biotechnology Industry Detected for Dyax (DYAX, ALKS, INCY) (F70)

2014-11-22@12:05:18 ET

2014-11-21@15:35:04 ET
Alkermes: The Winning Streak Continues (ALKS) (F71)

2014-11-20@11:55:53 ET
Alkermes (ALKS) Showing Bullish Technicals With Resistance At $56.74 (FBM)

2014-11-20@08:10:19 ET
Shares of Celldex Therapeutics Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (CLDX, SGMO, NPSP, ALKS, INCY) (F70)